Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma in 4-week treatment;Open-label, randomized, parallel-group comparative study - Budesonide/formoterol maintenance reliever therapy versus fluticasone furoate /vilanterol fixed-dose treatment of asthma on airway inflammation with adult asthma

Hiroshima Allergy and Respiratory Clinic0 个研究点目标入组 30 人开始时间: 2015年4月4日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•The patient with the following exclusion criteria is not enrolled 1)Patient with the drug allergy 2)Infection in the absence of effective antimicrobial agents, patients with deep mycosis 3)Patient with tuberculous disease, or respiratory infection 4)Patient with abnormal chest X-ray image 5)Patient with respiratory disease and other respiratory infections in 8 weeks before inclusion 6)Patient is using the beta-blockers, including eye drops or patients with systemic corticosteroids to less than 30 days 7)Patient with serious complications 8)Smoking history of 10 pack years or more and with less than 6 months or by non smoking 9)Patient with pregnancy, or who hope for a pregnancy 10)Patient was deemed inappropriate research attending physician is incorporated into this study

发起方

Hiroshima Allergy and Respiratory Clinic